Mpox: it's a global health emergency with children accounting for 80% of deaths. Bavarian Nordic has the only lifesaving vaccine for the Mpox virus, but it's charging $100 per shot. Central and W

Six months after Paul Chaplin said he was stepping down as CEO of Bavarian Nordic, the Danish biopharma has named Tarja Stenvall to the role.

La Organización Mundial de la Salud (OMS) ha dado un paso crucial al precalificar la primera vacuna contra la mpox. Esta decisión, basada en la evaluación de la Agencia Europea de Medicamentos y la información proporcionada por el fabricante Bavarian…

A private equity investment consortium has raised a takeover offer for Denmark's Bavarian Nordic, but some shareholders are still reluctant to sell

Mpox: it's a global health emergency with children accounting for 80% of deaths. Bavarian Nordic has the only lifesaving vaccine for the Mpox virus, but it's charging $100 per shot. Central and W

(Reuters) -Bavarian Nordic, subject of a takeover offer valuing the vaccine maker at about 19 billion Danish crowns ($3 billion), reported a higher than expected revenue for the second quarter on Friday, citing a strong performance in both its travel health and public preparedness businesses. WHY IT MATTERS A consortium led by Nordic Capital and Permira said in July it would launch a bid priced at 233 crowns per Bavarian Nordic (CSE:BAVA) share, which the Danish group’s board is recommending to its stakeholders. The vaccine maker’s main shareholder, Danish pension fund ATP, has said it has no intention of accepting the offer. ATP holds a 10% stake in Bavarian according to LSEG data. KEY QUOTE "If there are other interested parties, they know where we are," CEO Paul Chaplin said in an interview. "We’re not actively seeking additional offers, but it is now a public transaction." CONTEXT Bavarian Nordic is a key vaccine supplier to governments globally, including public health preparedness programmes in the United States, where Health Secretary Robert F. Kennedy Jr. has been making sweeping changes to vaccine policies. Chaplin had said in November that Bavarian was not concerned about the vaccine scepticism Donald Trump’s presidency and Kennedy’s appointment would bring into the U.S. health policies, a sentiment he reiterated on Friday. "We seem to be isolated from a lot of the vaccine scepticism discussions," he said. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. BY THE NUMBERS Bavarian reported quarterly revenue of 1.65 billion Danish crowns, exceeding a company-compiled consensus of 1.46 billion, based on estimates from three analysts. It now expects full-year revenue of 6.0 billion to 6.6 billion crowns, compared to the previous range of 5.7-6.7 billion, citing the strong travel health business and further clarity on the public preparedness business. WHAT’S NEXT Innosera, a company controlled by the consortium, is expected to publish an offer document on Tuesday at the latest. The takeover bid will be successful only if it gains acceptances for more than 90% of all shares. ($1 = 6.4376 Danish crowns)

Investing.com -- Bavarian Nordic (CSE:BAVA) has agreed to a 19 billion Danish kroner ($2.99 billion) takeover offer from private-equity firms Permira and Nordic Capital. The Danish vaccine maker’s shareholders will receive 233 kroner in cash per share under the deal terms. This represents a 21% premium to Bavarian Nordic’s closing price of 192.50 kroner on Wednesday, July 23, the day before the company confirmed it was in discussions with the consortium about a potential takeover. Bavarian Nordic’s board of directors has endorsed the proposal as attractive and recommended that shareholders accept the offer. The acquisition is expected to be completed in the fourth quarter of 2025, pending all necessary regulatory approvals and clearances. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Before you buy stock in BAVA, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is BAVA one of them?

KAMPALA, Uganda–(BUSINESS WIRE)–#BavarianNordic–As Sierra Leone grapples with the rapid escalation of mpox cases, AIDS Healthcare Foundation (AHF) calls for urgent global action to improve vaccination efforts for the response, including Bavarian Nordic lowering the price of the vaccine and transferring technology and know-how to regional manufacturers. AHF also urges wealthy nations to donate vaccine doses …